← Back to Search

Educational Materials for COVID-19 Vaccination During Pregnancy

N/A

Waitlist Available

Research Sponsored by University of Rochester

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Sex is female

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 month baseline compared to 6 month intervention

Awards & highlights

Study Summary

This trial will test whether sending educational materials to obstetrician's offices about the benefits of the COVID-19 vaccine for pregnant women will increase the number of pregnant women who get vaccinated.

Who is the study for?

This trial is for pregnant individuals who are eligible for the COVID-19 vaccine and have not yet received it. Participants must be female and currently affiliated with the participating OB/GYN sites, either as a provider, nurse, or staff member.Check my eligibility

What is being tested?

The study aims to increase maternal COVID-19 vaccination rates through a new intervention called VAX-MOM COVID-19 compared to standard care. It's a randomized controlled trial focusing on changing practices in obstetricians' offices.See study design

What are the potential side effects?

While specific side effects are not detailed here, common reactions to COVID-19 vaccines may include soreness at injection site, tiredness, headache, muscle pain, chills, fever, and nausea.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am female.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 month baseline compared to 6 month intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 month baseline compared to 6 month intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 month baseline compared to 6 month intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Rate of COVID-19 vaccination

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: VAX-MOM COVID-19 InterventionExperimental Treatment1 Intervention

Group II: Standard of CareActive Control1 Intervention

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of RochesterLead Sponsor

840 Previous Clinical Trials

526,250 Total Patients Enrolled

4 Trials studying COVID-19

2,530 Patients Enrolled for COVID-19

Centers for Disease Control and PreventionFED

875 Previous Clinical Trials

22,469,402 Total Patients Enrolled

16 Trials studying COVID-19

100,994 Patients Enrolled for COVID-19

University of California, Los AngelesOTHER

1,532 Previous Clinical Trials

10,257,268 Total Patients Enrolled

21 Trials studying COVID-19

865,604 Patients Enrolled for COVID-19

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many healthcare centers are implementing this trial in the city?

"The current medical trial requires recruitment from 26 different sites, including URMC Midwifery at Lattimore in Pasadena, Community OB (COB) in Los Angeles and Pasadena in Torrance."

Answered by AI

Is there still an opportunity to join the experiment?

"Currently, this clinical trial is not enrolling participants as indicated on clinicaltrials.gov. The study was first distributed for recruitment on October 21st 2022 and the most recent update to its status occurred November 8th 2022. Despite this particular trial's inactivity, 1169 other medical studies are actively searching for candidates at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

VAX-MOM COVID-19: Increasing Maternal COVID-19 Vaccination

Cynthia Rand 2022. "VAX-MOM COVID-19: Increasing Maternal COVID-19 Vaccination". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05570630.

All > Covid 19